409 related articles for article (PubMed ID: 27896485)
21. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C
Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342
[TBL] [Abstract][Full Text] [Related]
22. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
Silva TA; Azevedo H
J Proteomics; 2020 Oct; 229():103951. PubMed ID: 32860965
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids.
Matullo G; Naccarati A; Pardini B
Int J Cancer; 2016 May; 138(10):2334-45. PubMed ID: 26489968
[TBL] [Abstract][Full Text] [Related]
24. Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
Kim YJ; Kim WJ
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S77-88. PubMed ID: 27326410
[TBL] [Abstract][Full Text] [Related]
25. Urinary BLACAT1 as a non-invasive biomarker for bladder cancer.
El Sharkawi FZ; El Sabah M; Atya HB; Khaled HM
Mol Biol Rep; 2023 May; 50(5):4339-4345. PubMed ID: 36939965
[TBL] [Abstract][Full Text] [Related]
26. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
27. Novel biomarkers to predict response and prognosis in localized bladder cancer.
Lucca I; de Martino M; Klatte T; Shariat SF
Urol Clin North Am; 2015 May; 42(2):225-33, ix. PubMed ID: 25882564
[TBL] [Abstract][Full Text] [Related]
28. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy.
Groenendijk FH; de Jong J; Fransen van de Putte EE; Michaut M; Schlicker A; Peters D; Velds A; Nieuwland M; van den Heuvel MM; Kerkhoven RM; Wessels LF; Broeks A; van Rhijn BW; Bernards R; van der Heijden MS
Eur Urol; 2016 Mar; 69(3):384-8. PubMed ID: 25636205
[TBL] [Abstract][Full Text] [Related]
29. Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes.
Nagata M; Muto S; Horie S
Dis Markers; 2016; 2016():8205836. PubMed ID: 26924873
[TBL] [Abstract][Full Text] [Related]
30.
Kim K; Byun YJ; Zheng CM; Moon S; Jo SJ; Kang HW; Kim WT; Choi YH; Moon SK; Kim WJ; Piao XM; Yun SJ
Investig Clin Urol; 2024 Jan; 65(1):94-103. PubMed ID: 38197756
[TBL] [Abstract][Full Text] [Related]
31. Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.
Contreras-Sanz A; Roberts ME; Seiler R; Black PC
Int J Urol; 2017 Jan; 24(1):7-15. PubMed ID: 27597124
[TBL] [Abstract][Full Text] [Related]
32. Circulating Tumour DNA in Muscle-Invasive Bladder Cancer.
Tan MP; Attard G; Huddart RA
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30158468
[TBL] [Abstract][Full Text] [Related]
33. Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy.
da Costa JB; Gibb EA; Nykopp TK; Mannas M; Wyatt AW; Black PC
Urol Oncol; 2022 Jul; 40(7):287-294. PubMed ID: 30528886
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs: Key Players in Bladder Cancer.
Li Q; Wang H; Peng H; Huang Q; Huyan T; Huang Q; Yang H; Shi J
Mol Diagn Ther; 2019 Oct; 23(5):579-601. PubMed ID: 31325035
[TBL] [Abstract][Full Text] [Related]
35. Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
Critelli R; Fasanelli F; Oderda M; Polidoro S; Assumma MB; Viberti C; Preto M; Gontero P; Cucchiarale G; Lurkin I; Zwarthoff EC; Vineis P; Sacerdote C; Matullo G; Naccarati A
Oncotarget; 2016 Oct; 7(41):67435-67448. PubMed ID: 27611947
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers for prognosis and treatment selection in advanced bladder cancer patients.
Ru Y; Dancik GM; Theodorescu D
Curr Opin Urol; 2011 Sep; 21(5):420-7. PubMed ID: 21814055
[TBL] [Abstract][Full Text] [Related]
37. Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer.
Pardini B; Viberti C; Naccarati A; Allione A; Oderda M; Critelli R; Preto M; Zijno A; Cucchiarale G; Gontero P; Vineis P; Sacerdote C; Matullo G
Br J Cancer; 2017 Jan; 116(2):202-210. PubMed ID: 27959887
[TBL] [Abstract][Full Text] [Related]
38. Research Progress of Urine Biomarkers in the Diagnosis, Treatment, and Prognosis of Bladder Cancer.
Jin F; Shahid M; Kim J
Adv Exp Med Biol; 2021; 1306():61-80. PubMed ID: 33959906
[TBL] [Abstract][Full Text] [Related]
39. Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer.
Maas M; Walz S; Stühler V; Aufderklamm S; Rausch S; Bedke J; Stenzl A; Todenhöfer T
Expert Rev Mol Diagn; 2018 May; 18(5):443-455. PubMed ID: 29707982
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
